Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Washington D.C. – A dramatic escalation in trade tactics is unfolding as the current administration leverages newly imposed 100% tariffs to compel pharmaceutical companies, ranging from industry giants to emerging biotech startups, … Read more
Potential 100% Tariff on Imported Prescription Drugs Sparks Concern WASHINGTON – The administration is reportedly preparing an executive order that could impose a substantial 100% tariff on all prescription medications and their key ingredients sourced from overseas. This dramatic measure, if enacted, threatens to significantly increase the cost of life-saving drugs for Americans and disrupt … Read more
White House Unveils Draft Legislation Aiming to Lower Prescription Drug Costs WASHINGTON – The White House has completed drafting legislative text intended to address rising prescription drug prices, initiating discussions with leaders from over a dozen major pharmaceutical companies. This move represents a significant step in the administration’s broader healthcare reform agenda, particularly as it … Read more
Public Opinion Shifts: Trump Receives More Credit for Potential Drug Price Reductions WASHINGTON – The persistent challenge of lowering prescription drug costs remains a central focus for both current and past administrations. However, recent data indicates a surprising trend: a greater proportion of Americans attribute potential future reductions in drug prices to the policies enacted … Read more